subutex Search Results


90
Millipore d4 buprenorphine internal standard
D4 Buprenorphine Internal Standard, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/Buprenorphine+(0%2E1+mg%2Fml)+in+Methanol/pmc09544110-53-24-27
Average 90 stars, based on 1 article reviews
d4 buprenorphine internal standard - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Millipore buprenorphine 3 β d glucuronide
Buprenorphine 3 β D Glucuronide, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/Buprenorphine-3beta-D-glucuronide+(0%2E1+mg%2FmL)+in+Methanol/pmc03777223-162-19-28
Average 86 stars, based on 1 article reviews
buprenorphine 3 β d glucuronide - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
LGC Standards buprenorphine d4
Buprenorphine D4, supplied by LGC Standards, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/Buprenorphine/pmc08236049-92-16-17
Average 94 stars, based on 1 article reviews
buprenorphine d4 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Toronto Research Chemicals buprenorphine hydrochloride
Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, <t>buprenorphine,</t> and diclofenac on 4-methylumbelliferone glucuronide formation by rat liver microsomes. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)
Buprenorphine Hydrochloride, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/Buprenorphine+Hydrochloride/pmc04660513-40-3-8
Average 86 stars, based on 1 article reviews
buprenorphine hydrochloride - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

93
ZeptoMetrix corporation slow release buprenorphine
Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, <t>buprenorphine,</t> and diclofenac on 4-methylumbelliferone glucuronide formation by rat liver microsomes. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)
Slow Release Buprenorphine, supplied by ZeptoMetrix corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/Buprenorphine/pmc13066022-281-10-14
Average 93 stars, based on 1 article reviews
slow release buprenorphine - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Toronto Research Chemicals buprenorphine
HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or <t>buprenorphine</t> (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.
Buprenorphine, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/Buprenorphine/pmc09865058-132-11-14
Average 94 stars, based on 1 article reviews
buprenorphine - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
Toronto Research Chemicals buprenorphine d3
HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or <t>buprenorphine</t> (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.
Buprenorphine D3, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/Buprenorphine-d3+Hydrochloride/pmc04163085-64-12-14
Average 91 stars, based on 1 article reviews
buprenorphine d3 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

86
Millipore buprenorphine d4
HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or <t>buprenorphine</t> (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.
Buprenorphine D4, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/Buprenorphine+(1%2E0+mg%2Fml)+in+Methanol/pmc03663890-60-6-12
Average 86 stars, based on 1 article reviews
buprenorphine d4 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Monosol Rx subutex
HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or <t>buprenorphine</t> (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.
Subutex, supplied by Monosol Rx, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/subutex/pmc03225026-207-41-16
Average 90 stars, based on 1 article reviews
subutex - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Reckitt Benckiser buprenorphine subutex
HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or <t>buprenorphine</t> (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.
Buprenorphine Subutex, supplied by Reckitt Benckiser, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/buprenorphine+subutex/pmc02365704-99-7-15
Average 90 stars, based on 1 article reviews
buprenorphine subutex - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Reckitt Benckiser subutex
HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or <t>buprenorphine</t> (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.
Subutex, supplied by Reckitt Benckiser, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/subutex/pmc02978797-75-22-24
Average 90 stars, based on 1 article reviews
subutex - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co 0.3-g/ml temgesic solution
HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or <t>buprenorphine</t> (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.
0.3 G/Ml Temgesic Solution, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/subutex/0+3+temgesic+solution/pmc05117771-59-16-18
Average 90 stars, based on 1 article reviews
0.3-g/ml temgesic solution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, buprenorphine, and diclofenac on 4-methylumbelliferone glucuronide formation by rat liver microsomes. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)

Journal: Pharmacognosy Research

Article Title: Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver microsomes and recombinant human uridine 5’-diphospho-glucuronosyltransferase isoforms

doi: 10.4103/0974-8490.159580

Figure Lengend Snippet: Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, buprenorphine, and diclofenac on 4-methylumbelliferone glucuronide formation by rat liver microsomes. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)

Article Snippet: Ketamine hydrochloride and buprenorphine hydrochloride were purchased from Toronto Research Chemicals Inc. (North York, ON, Canada).

Techniques: Activity Assay, Control

Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, buprenorphine, and diclofenac on 4-methylumbelliferone glucuronide formation by recombinant human UGT2B7 isoform. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)

Journal: Pharmacognosy Research

Article Title: Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver microsomes and recombinant human uridine 5’-diphospho-glucuronosyltransferase isoforms

doi: 10.4103/0974-8490.159580

Figure Lengend Snippet: Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, buprenorphine, and diclofenac on 4-methylumbelliferone glucuronide formation by recombinant human UGT2B7 isoform. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)

Article Snippet: Ketamine hydrochloride and buprenorphine hydrochloride were purchased from Toronto Research Chemicals Inc. (North York, ON, Canada).

Techniques: Recombinant, Activity Assay, Control

Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, buprenorphine, and diclofenac on 4-methylumbelliferone glucuronide formation by human liver microsomes. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)

Journal: Pharmacognosy Research

Article Title: Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver microsomes and recombinant human uridine 5’-diphospho-glucuronosyltransferase isoforms

doi: 10.4103/0974-8490.159580

Figure Lengend Snippet: Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, buprenorphine, and diclofenac on 4-methylumbelliferone glucuronide formation by human liver microsomes. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)

Article Snippet: Ketamine hydrochloride and buprenorphine hydrochloride were purchased from Toronto Research Chemicals Inc. (North York, ON, Canada).

Techniques: Activity Assay, Control

Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, buprenorphine, and diclofenac on 4-methylumbelliferone glucuronide formation by recombinant human UGT1A1 isoform. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)

Journal: Pharmacognosy Research

Article Title: Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver microsomes and recombinant human uridine 5’-diphospho-glucuronosyltransferase isoforms

doi: 10.4103/0974-8490.159580

Figure Lengend Snippet: Inhibitory effects of mitragynine, 7-hydroxymitragynine, ketamine, buprenorphine, and diclofenac on 4-methylumbelliferone glucuronide formation by recombinant human UGT1A1 isoform. Panels to the right show inhibitor concentrations. Each bar represents the mean percentage activity relative to control ± standard error of mean for three independent measurements ( n = 3). Statistical analysis was conducted using one-way ANOVA and Dunnett test. * P < 0.05 versus control (no inhibitor)

Article Snippet: Ketamine hydrochloride and buprenorphine hydrochloride were purchased from Toronto Research Chemicals Inc. (North York, ON, Canada).

Techniques: Recombinant, Activity Assay, Control

HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or buprenorphine (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.

Journal: International Journal of Molecular Sciences

Article Title: Opioid-Modulated Receptor Localization and Erk1/2 Phosphorylation in Cells Coexpressing μ-Opioid and Nociceptin Receptors

doi: 10.3390/ijms24021048

Figure Lengend Snippet: HEK 293 cells transiently transfected with MOP-CFP and NOP-YFP were serum-starved overnight; vehicle (ddH 2 O), morphine (1 μM), or buprenorphine (1 μM) was added to cells immediately before FRET/SPT measurements. ( A – C ) present the results obtained under the conditions of pre-treatment, post-bup, and post-mor, respectively. The images of MOP-CPF (shown in cyan), NOP-YFP (shown in yellow), FRET ratio (%), and a magnified view from a white box in the respective FRET ratio image are shown for each condition from left to right. ( D ) is the control image taken from the MOP-CFP-channel at the pretreatment condition, which is used to confirm whether the receptors are properly expressed on the cell surface. ( E ) The histograms of the FRET ratio obtained from each condition were fitted to Gaussian distributions, indicating the peak value with a standard deviation. Scale bar = 20 μm. The bin size of the histogram = 0.01. Twelve cells were used for statistical analysis in each condition.

Article Snippet: Morphine (1 μM, Toronto Research Chemicals, North York, ON, Canada) or buprenorphine (1 μM, Toronto Research Chemicals) was added to cells shortly before starting FRET/SPT measurements and present in the serum-free medium throughout the whole experiment.

Techniques: Transfection, Control, Standard Deviation

Representative confocal images ( A ) and colocalization rates of MOP and NOP on lipid rafts (red) ( B ) from HEK 293 cells stably expressing HA-tagged MOP (green) and/or myc-tagged NOP (magenta) after exposure to morphine (1 μM) or buprenorphine (1 μM) for 20 min at 4 °C. The inset panels display higher magnification images highlighting the colocalization. Scale bars are equal to 10 μm. Each bar represents the mean ± SE value of the percentage of ROI colocalization derived from five independent experiments with 4–6 individual cell images in each group.

Journal: International Journal of Molecular Sciences

Article Title: Opioid-Modulated Receptor Localization and Erk1/2 Phosphorylation in Cells Coexpressing μ-Opioid and Nociceptin Receptors

doi: 10.3390/ijms24021048

Figure Lengend Snippet: Representative confocal images ( A ) and colocalization rates of MOP and NOP on lipid rafts (red) ( B ) from HEK 293 cells stably expressing HA-tagged MOP (green) and/or myc-tagged NOP (magenta) after exposure to morphine (1 μM) or buprenorphine (1 μM) for 20 min at 4 °C. The inset panels display higher magnification images highlighting the colocalization. Scale bars are equal to 10 μm. Each bar represents the mean ± SE value of the percentage of ROI colocalization derived from five independent experiments with 4–6 individual cell images in each group.

Article Snippet: Morphine (1 μM, Toronto Research Chemicals, North York, ON, Canada) or buprenorphine (1 μM, Toronto Research Chemicals) was added to cells shortly before starting FRET/SPT measurements and present in the serum-free medium throughout the whole experiment.

Techniques: Stable Transfection, Expressing, Derivative Assay

Representative immunoblots of Erk1/2 (p44/p42 MAPK) phosphorylation after stimulation with ( A ) morphine and ( B ) buprenorphine in cells stably expressing MOP, NOP, and MOP+NOP receptors. Immunoblotting using anti-phospho-p44/p42 MAPK (Erk1/2) rabbit polyclonal and anti-p44/42 MAPK (Erk1/2) rabbit monoclonal antibodies was performed to visualize opioid-induced phosphorylation of Erk1/2 (p44 MAPK-P and p42 MAPK-P) and total Erk1/2 (p44 MAPK and p42 MAPK), respectively. ( C ) Dose–response curves of the immunoblots. The density of phospho-p44/p42 MAPK versus the density of p44/42 MAPK in control cells (with vehicle treatment) was considered to be 1. All the experiments were repeated no less than four times, and the values represent the average ± SE.

Journal: International Journal of Molecular Sciences

Article Title: Opioid-Modulated Receptor Localization and Erk1/2 Phosphorylation in Cells Coexpressing μ-Opioid and Nociceptin Receptors

doi: 10.3390/ijms24021048

Figure Lengend Snippet: Representative immunoblots of Erk1/2 (p44/p42 MAPK) phosphorylation after stimulation with ( A ) morphine and ( B ) buprenorphine in cells stably expressing MOP, NOP, and MOP+NOP receptors. Immunoblotting using anti-phospho-p44/p42 MAPK (Erk1/2) rabbit polyclonal and anti-p44/42 MAPK (Erk1/2) rabbit monoclonal antibodies was performed to visualize opioid-induced phosphorylation of Erk1/2 (p44 MAPK-P and p42 MAPK-P) and total Erk1/2 (p44 MAPK and p42 MAPK), respectively. ( C ) Dose–response curves of the immunoblots. The density of phospho-p44/p42 MAPK versus the density of p44/42 MAPK in control cells (with vehicle treatment) was considered to be 1. All the experiments were repeated no less than four times, and the values represent the average ± SE.

Article Snippet: Morphine (1 μM, Toronto Research Chemicals, North York, ON, Canada) or buprenorphine (1 μM, Toronto Research Chemicals) was added to cells shortly before starting FRET/SPT measurements and present in the serum-free medium throughout the whole experiment.

Techniques: Western Blot, Phospho-proteomics, Stable Transfection, Expressing, Bioprocessing, Control